GlassScriptPhysician profile
Lori A Spencer
NPI 1871797936
$12,503.46
in general payments reported to CMS, 2019-2025
34 companies · $2,736 in 2025
The $2,736 reported for 2025 was more than what 83% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,480 · 2020: $848 · 2021: $1,494 · 2022: $2,113 · 2023: $1,842 · 2024: $1,990 · 2025: $2,736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,118 · Education: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,118.33 |
| Education | $449.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,071.33 | 2019-2025 | Skyrizi, Rinvoq |
| Leo Pharma INC. | $1,753.43 | 2019-2025 | Adbry, Anzupgo, Spevigo |
| Novartis Pharmaceuticals Corporation | $1,229.17 | 2019-2025 | |
| Pfizer INC. | $1,164.59 | 2019-2025 | |
| Janssen Biotech, INC. | $974.25 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Lilly USA, LLC | $891.48 | 2019-2025 | Taltz, Ebglyss, Zepbound |
| Ucb, INC. | $566.82 | 2019-2025 | Bimzelx, Cimzia |
| Incyte Corporation | $533.77 | 2021-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $518.65 | 2022-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $416.62 | 2019-2025 | Ilumya |
| Genzyme Corporation | $314.92 | 2019-2025 | |
| Amgen INC. | $297.80 | 2021-2025 | Otezla, Otezla |
| Arcutis Biotherapeutics, INC. | $268.39 | 2023-2025 | Zoryve |
| Dermavant Sciences, INC. | $266.58 | 2023-2024 | Vtama |
| Galderma Laboratories, L.P. | $242.18 | 2019-2025 | Aklief, Oracea, Epsolay |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $227.06 | 2019-2025 | Dupixent, Libtayo |
| Dermira, INC. | $135.11 | 2019 | |
| Organon LLC | $115.61 | 2025 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $68.38 | 2019-2024 | Siliq |
| Vyne Pharmaceuticals INC. | $62.54 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.20 | 2022-2025 | Spevigo |
| Botanix Sb INC | $42.22 | 2025 | Sofdra |
| Celgene Corporation | $41.57 | 2019 | |
| Genentech USA, INC. | $31.68 | 2022 | |
| Janssen Scientific Affairs, LLC | $30.99 | 2021 | |
| Mallinckrodt Hospital Products INC. | $26.54 | 2024 | Acthar |
| Mission Pharmacal Company | $24.79 | 2019 | |
| Journey Medical Corporation | $23.95 | 2023 | |
| Mayne Pharma Commercial LLC | $23.66 | 2020 | |
| Almirall LLC | $18.33 | 2022 | |
| Biofrontera INC. | $16.33 | 2019 | |
| Epi Health, LLC | $16.15 | 2021 | |
| Strata Skin Sciences, INC. | $15.25 | 2025 | Xtrac |
| Fresenius Kabi USA, LLC | $14.12 | 2023 | Idacio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.